FDA applicant

Applied BioCode, Inc.

Santa Fe Springs, CA5 decisions2018–20260 recalls

FDA records 5 decisions for Applied BioCode, Inc. (Santa Fe Springs, CA) from 2018 to 2026: 5 510(k) clearances. Most are in product codes PCH (Gastrointestinal Pathogen Panel Multiplex…) and OCC (Respiratory Virus Panel Nucleic Acid Assay…). Since 2016 its 510(k)s took a median of 109 days from receipt to decision, against 105 for FDA’s reviews in the same codes and years. Its devices cite 5 predicates, 3 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, microbiology panel, where it files most

How often FDA has decided Applied BioCode, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2018high 2 (2019) · low 0 (2020)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2018.

FIG. 1 — Applied BioCode, Inc. by year, 2018–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Applied BioCode, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Applied BioCode, Inc.

Which product codes does it file in?

How long do its 510(k) reviews take?

Whose devices does it build on?

Which of its devices are cited most?

What has FDA decided for it lately?